QELLQIA Trademark

Trademark Overview

On Friday, September 24, 2021, a trademark application was filed for QELLQIA with the United States Patent and Trademark Office. The USPTO has given the QELLQIA trademark a serial number of 79327023. The federal status of this trademark filing is REGISTERED as of Tuesday, September 27, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The QELLQIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases
qellqia

General Information

Serial Number79327023
Word MarkQELLQIA
Filing DateFriday, September 24, 2021
Status700 - REGISTERED
Status DateTuesday, September 27, 2022
Registration Number6854772
Registration DateTuesday, September 27, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Monday, January 23, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, January 23, 2023FINAL DISPOSITION PROCESSED
Tuesday, December 27, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 27, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 19, 2022NOTIFICATION PROCESSED BY IB
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 29, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 20, 2022REFUSAL PROCESSED BY IB
Friday, January 28, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 28, 2022REFUSAL PROCESSED BY MPU
Thursday, January 6, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 5, 2022NON-FINAL ACTION WRITTEN
Tuesday, January 4, 2022ASSIGNED TO EXAMINER
Tuesday, December 21, 2021APPLICATION FILING RECEIPT MAILED
Thursday, December 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 15, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 2, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

qellqia treatment diseases infectious cancer immunological therapeutics immune preparations namely cell